| Literature DB >> 27956698 |
Serge Summermatter1, Anais Bouzan1, Eliane Pierrel1, Stefan Melly1, Daniela Stauffer1, Sabine Gutzwiller1, Erin Nolin2, Christina Dornelas2, Christy Fryer2, Juliet Leighton-Davies1, David J Glass3, Brigitte Fournier4.
Abstract
Metallothioneins are proteins that are involved in intracellular zinc storage and transport. Their expression levels have been reported to be elevated in several settings of skeletal muscle atrophy. We therefore investigated the effect of metallothionein blockade on skeletal muscle anabolism in vitro and in vivo We found that concomitant abrogation of metallothioneins 1 and 2 results in activation of the Akt pathway and increases in myotube size, in type IIb fiber hypertrophy, and ultimately in muscle strength. Importantly, the beneficial effects of metallothionein blockade on muscle mass and function was also observed in the setting of glucocorticoid addition, which is a strong atrophy-inducing stimulus. Given the blockade of atrophy and the preservation of strength in atrophy-inducing settings, these results suggest that blockade of metallothioneins 1 and 2 constitutes a promising approach for the treatment of conditions which result in muscle atrophy.Entities:
Keywords: muscle metabolism
Mesh:
Substances:
Year: 2017 PMID: 27956698 PMCID: PMC5311239 DOI: 10.1128/MCB.00305-16
Source DB: PubMed Journal: Mol Cell Biol ISSN: 0270-7306 Impact factor: 4.272